Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE).

F

Fondation Ophtalmologique Adolphe de Rothschild

Status and phase

Terminated
Phase 4

Conditions

Parkinson's Disease

Treatments

Drug: Apomorphine

Study type

Interventional

Funder types

NETWORK

Identifiers

NCT02688465
CHH_2016_01

Details and patient eligibility

About

Parkinson's disease is not only a pathology of movements. There are many non-motor symptoms that complicate and impair patients' quality of life. Among those disorders are sleep disorders. Insomnia is the most frequent symptom. Most patients report 2-5 awakenings per night and long periods of awakening which occupy 30 to 40% of their night. Apomorphine is a dopamine agonist that may be administered with a pump . The objective of the study is to assess changes in the quality of sleep in Parkinson's disease patients treated with an apomorphine pump.

Enrollment

15 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Parkinson's disease patients for whom a treatment with an apomorphine pump is indicated

Exclusion criteria

  • atypical parkinsonian syndrome
  • cognitive impairment
  • pregnancy
  • breast feeding
  • patient under a legal protection procedure
  • patient denying to participate to the study
  • lack of affiliation to a social security system

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

15 participants in 1 patient group

Apomorphine pump
Experimental group
Treatment:
Drug: Apomorphine

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems